GenderBiology.net

Gender Differences Revealed In The Effects Of Long-Term Alcoholism

SOURCE:  Medical News

http://www.ncbi.nlm.nih.gov/pubmed/Today

DATE: August 10, 2012

EXCERPT: "A new study, published online in the journal Alcoholism: Clinical and Experimental Research, shows that the impact of long-term alcohol abuse on white matter brain volume is different for men and women, which indicates that women recover their white matter brain volume faster than men with abstinence."  more

RELATED PUBMED LINK:

Ruiz SM, Oscar-Berman M, Sawyer KS, Valmas MM, Urban T, Harris GJ. Drinking History Associations with Regional White Matter Volumes in Alcoholic Men and Women. Alcohol Clin Exp Res. 2012 Jun 22. doi: 10.1111/j.1530-0277.2012.01862.x. 


*Note: if you do not have access to this journal, contact your local librarian for assistance in accessing this article through library resources.

Study Finds Declining Testosterone Levels In Men Not Part Of Normal Aging

SOURCE:  Medical News Today

DATE:  June 25, 2012

EXCERPT: "A new study finds that a drop in testosterone levels over time is more likely to result from a man's behavioral and health changes than by aging. ...  "Declining testosterone levels are not an inevitable part of the aging process, as many people think," said study co-author  ..."  more

RELATED LINK:  style="color: #936386">

Presented by Gary Wittert at the ENDO 2012: The Endocrine Society's 94th Annual Meeting & Expo,  23-26 June 2012, [Houston]

Low-Dose Vitamin D May Not Prevent Fractures in Healthy Women – What About Higher Doses?

SOURCE:  Newswise

DATE:  June 15, 2012

EXCERPT: "Vitamin D and calcium are dietary requirements, but it’s unclear how much is best for us. New draft findings by the United States Preventive Services Task Force conclude that for healthy, postmenopausal women, daily supplementation with low levels of vitamin D — up to 400 international units — combined with 1,000 milligrams of calcium, does not reduce fracture risk."   more

Osteoporosis Drugs May Lead to Eye Trouble

SOURCE:  MedlinePlus (HealthDay)

DATE:  April 2, 2012

EXCERPT:  "First-time users of osteoporosis drugs called oral bisphosphonates may be at increased risk for serious inflammatory eye disease, a new study contends.

Oral bisphosphonates, such as Fosamax and Actonel, are the most commonly prescribed class of drugs to prevent or slow osteoporosis, a disease that causes very weak bones. Previous studies have linked the drugs to problems such as unusual fractures, irregular heartbeat and esophageal and colon cancer.

In addition, some case reports have shown an association between the drugs and inflammatory eye diseases -- anterior uveitis and scleritis -- that can cause serious vision impairment."  more

RELATED PUBMED LINK:

Etminan M, Forooghian F, Maberley D. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study. CMAJ. 2012 May 15;184(8):E431-4. Epub 2012 Apr 2.

*Note: if you do not have access to this journal, contact your local librarian for assistance in accessing this article through library resources.

 

Gender Gaps Discovered in Overall Use of Prescription Drugs, Adherence Patterns and Medical Management

SOURCE:  Newswise

DATE:  March 21, 2012

EXCERPT:  "Women use more prescription drugs than men; yet they are not prescribed proper amounts. In a new study presented at Women's Health 2012: The 20th Annual Congress by Medco Health Solutions, Inc. and the Society for Women's Health Research (SWHR) women are prescribed more drugs than men, have poorer adherence rates to using the drugs than men, and, perhaps most surprisingly, lag behind men in receiving the appropriate drugs for their documented diseases.

Historically, clinical trials have included predominantly men, but medications affect men and women differently. Because sex differences in prescription drug absorption, metabolism and dosage have not been properly researched, women may be left to suffer the consequences.

...


This landmark study shows that gender-specific dosing is desperately needed in modern medicine. SWHR has long advocated for sex-specific dosing research and guidance on all drugs to prevent harmful reactions in women and to improve their overall health."   more

RELATED LINK:

Presented by Medco Health Solutions, Inc. and the Society for Women's Health Research (SWHR) at the Women's Health 2012: The 20th Annual Congress  meeting, 16-18 Mar 2012, Washington, D.C.

Triggers differ for addicted men, women

SOURCE:  Futurity

DATE:  February 1, 2012

EXCERPT:  "The areas of the brain associated with craving have different triggers in cocaine-dependent men and women, a finding that suggests they may benefit from different treatment options."  more

RELATED PUBMED LINK:

Potenza MN, Hong KI, Lacadie CM, Fulbright RK, Tuit KL, Sinha R. Neural Correlates of Stress-Induced and Cue-Induced Drug Craving: Influences of Sex and Cocaine Dependence. Am J Psychiatry. 2012 Jan 31.

*Note: if you do not have access to this journal, contact your local librarian for assistance in accessing this article through library resources.

Both Sexes Enjoy Statin Benefits

  SOURCE: MedPage Today

DATE:  January 30, 3012

EXCERPT:  "Statins cut cardiovascular events and all-cause mortality in both men and women, a meta-analysis showed."  more

RELATED PUBMED LINK:

Kostis WJ, Cheng JQ, Dobrzynski JM, Cabrera J, Kostis JB. Meta-analysis of statin effects in women versus men. J Am Coll Cardiol. 2012 Feb 7;59(6):572-82.

*Note: if you do not have access to this journal, contact your local librarian for assistance in accessing this article through library resources.

Statins Raise Diabetes Risk In Post-Menopausal Females

SOURCE: Medical News Today

DATE:  January 10, 2012

EXCERPT:  "Post-menopausal females who take statins have been found to have a higher risk of developing diabetes, researchers from various medical schools in Massachusetts and other US faculties reported in Archives of Internal Medicine. However, the authors emphasized that the benefits of statins - cholesterol-lowering medications - still outweigh the risks, even for females in the mentioned age-groups."    more

RELATED PUBMED LINK:

Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, Manson JE, Qiao Y, Liu S, Merriam PA, Rahilly-Tierny C, Thomas F, Berger JS, Ockene JK, Curb JD, Ma Y. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med. 2012 Jan 23;172(2):144-52. Epub 2012 Jan 9.

*Note: if you do not have access to this journal, contact your local librarian for assistance in accessing this article through library resources.

Aspirin Not Worth Risks for Healthy Women

SOURCE:  MedlinePlus.gov (Reuters)

DATE:    November 24, 2011

EXCERPT: "Aspirin is a bad bargain for healthy women trying to stave off heart attacks or strokes, although it's commonly used for that purpose, according to Dutch researchers.

In a new report, they say 50 women will need to take the medication for 10 years for just one to be helped -- and that's assuming they are at high risk to begin with."    more

RELATED PUBMED LINK:

Dorresteijn JA, Visseren FL, Ridker PM, Paynter NP, Wassink AM, Buring JE, van der Graaf Y, Cook NR. Aspirin for primary prevention of vascular events in women: individualized prediction of treatment effects. Eur Heart J. 2011 Dec;32(23):2962-9.

*Note: if you do not have access to this journal, contact your local librarian for assistance in accessing this article through library resources.

NSAIDs May Up Women’s Risk of Crohn’s Disease

SOURCE: MedPage Today

DATE:  November 1, 2011

EXCERPT: "Women who use nonsteroidal anti-inflammatory drugs -- but not aspirin or acetaminophen -- have a slightly higher risk of developing Crohn’s disease and ulcerative colitis, a researcher said here."   more

RELATED:

Ananthakrishnan, Ashwin, et al. "A prospective study of aspirin, non-steroidal anti-inflammatory drug use and risk of Crohn's disease and ulcerative colitis" Abstract 6. Presented at the American College of Gastroenterology 2011 Annual Scienctific Meeting and Postgraduate Course,  28 October - 2 November, 2011, Washington, D.C.